Zobrazeno 1 - 10
of 33
pro vyhledávání: '"JS Neergaard"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S457-S458 (2023)
Introduction: Concizumab is a once-daily prophylactic treatment in development for haemophilia A or B with or without inhibitors, and it is potentially the first treatment for haemophilia patients to be delivered subcutaneously using a prefilled, mul
Externí odkaz:
https://doaj.org/article/61480a7e87804a09b68475592bbd6308
Autor:
K Hampton, P Knoebl, J Odgaard-Jensen, O Stasyshyn, JJT Zaw, JS Neergaard, B Zulfikar, GG Fabbron
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S458-S459 (2023)
Introduction: Concizumab is a humanised, recombinant monoclonal antibody administered to patients with haemophilia A/B with inhibitors (HAwI/HBwI) as a once-daily prophylaxis (PPX) in the phase 3 explorer7 study (NCT04083781). In the primary analysis
Externí odkaz:
https://doaj.org/article/569e701ffd8c4f2c9b5709952b466343
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S458- (2023)
Introduction: Concizumab is a humanised, monoclonal anti-tissue factor pathway inhibitor antibody. In explorer7, a phase 3 study (NCT04083781), patients with haemophilia A or B with inhibitors (HAwI/HBwI) received once-daily subcutaneous prophylactic
Externí odkaz:
https://doaj.org/article/c982177742ae42a2884147f62aae1919
Autor:
Windyga J; Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Apte S; Sahyadri Speciality Hospital, Pune, India., Frei-Jones M; Pediatric Hematology-Oncology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Fujii T; Hiroshima University Hospital, Hiroshima, Japan., Lyu CJ; Yonsei University Severance Hospital, Seoul, Korea., Villarreal Martinez L; Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico., Sathar J; Hospital Ampang, Ampang, Selangor Darul Ehsan, Malaysia., Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Tran H; The Alfred Hospital, Melbourne, Victoria, Australia., Zozulya N; National Medical Center for Hematology, Moscow, Russia., Brown Frandsen R; Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Novo Nordisk A/S, Søborg, Denmark., Thaung Zaw JJ; Novo Nordisk A/S, Søborg, Denmark., Mahlangu J; University of the Witwatersrand and NHLS, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Nov; Vol. 113 (5), pp. 631-640. Date of Electronic Publication: 2024 Jul 19.
Autor:
Akhtar S; Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark., Berg B; Clinical Operations, Obesity, Liver Diseases & Devices, Novo Nordisk A/S, Søborg, Denmark., Medina J; Medical & Science, Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark., Gonczi MN; Human Factors, Research Collective, Tempe, AZ, USA., Hamilton S; Rare Endocrine Rare Renal Diseases, Novo Nordisk Inc, Plainsboro, NJ, USA., Hildebrand E; Human Factors, Research Collective, Tempe, AZ, USA., Kelepouris N; Rare Endocrine Disorders, Novo Nordisk Inc, Plainsboro, NJ, USA., Neergaard JS; Safety Surveillance, Cardiovascular Disease, Novo Nordisk A/S, Søborg, Denmark., Sværke C; Global Development, Novo Nordisk A/S, Søborg, Denmark., Ter-Borch G; Clinical Operations, Obesity, Liver Diseases & Devices, Novo Nordisk A/S, Søborg, Denmark., Rasmussen NK; Medical & Science, Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark.
Publikováno v:
Medical devices (Auckland, N.Z.) [Med Devices (Auckl)] 2024 Oct 30; Vol. 17, pp. 427-439. Date of Electronic Publication: 2024 Oct 30 (Print Publication: 2024).
Autor:
Brod M; Health Outcomes Research, The Brod Group, Mill Valley, California, USA., Bushnell DM; Patient Centered Research, Evidera | PPD, Bethesda, Maryland, USA., Busk AK; Global Rare Disease Access and Pricing, Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Clinical Development & Project Leadership, Novo Nordisk A/S, Søborg, Denmark.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.
Autor:
Kahr Rasmussen N; Medical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark., Berg B; Clinical Operations, Novo Nordisk A/S, Søborg, Denmark., Christiansen ASL; Biostatistics, Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Medical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark., Ter-Borch G; Clinical Operations, Novo Nordisk A/S, Søborg, Denmark., Hildebrand EA; Research Collective LLC, Tempe, AZ, USA., Gonczi M; Research Collective LLC, Tempe, AZ, USA., Sparre T; Medical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark.
Publikováno v:
Patient preference and adherence [Patient Prefer Adherence] 2024 Aug 14; Vol. 18, pp. 1713-1727. Date of Electronic Publication: 2024 Aug 14 (Print Publication: 2024).
Autor:
Tran H; Ronald Sawers Haemophilia Centre, The Alfred Hospital, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., von Mackensen S; Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Abraham A; Department of Hematology, Christian Medical College, Vellore, India., Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy., Hampton K; Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK., Knoebl P; Division of Hematology and Hemostasis, Department of Medicine 1, Medical University of Vienna, Vienna, Austria., Linari S; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy., Odgaard-Jensen J; Biostatistics HTA, Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Safety Surveillance CVD I, Novo Nordisk A/S, Søborg, Denmark., Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Thaung Zaw JJ; Medical & Science Rare Bleeding Disorders, Novo Nordisk A/S, Søborg, Denmark., Zulfikar B; Division of Pediatric Hematology-Oncology, Istanbul University Oncology Institute, Istanbul, Turkey., Shapiro A; Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
Publikováno v:
Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2024 Jun 17; Vol. 8 (4), pp. 102476. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).
Autor:
Domeneguetti R, Stefszky M, Herrmann H, Silberhorn C, Andersen UL, Neergaard-Nielsen JS, Gehring T
Publikováno v:
Optics letters [Opt Lett] 2023 Jun 01; Vol. 48 (11), pp. 2999-3002.
Autor:
Nielsen JAH; Center for Macroscopic Quantum States (bigQ), Department of Physics, Technical University of Denmark, Fysikvej, 2800 Kongens Lyngby, Denmark., Neergaard-Nielsen JS; Center for Macroscopic Quantum States (bigQ), Department of Physics, Technical University of Denmark, Fysikvej, 2800 Kongens Lyngby, Denmark., Gehring T; Center for Macroscopic Quantum States (bigQ), Department of Physics, Technical University of Denmark, Fysikvej, 2800 Kongens Lyngby, Denmark., Andersen UL; Center for Macroscopic Quantum States (bigQ), Department of Physics, Technical University of Denmark, Fysikvej, 2800 Kongens Lyngby, Denmark.
Publikováno v:
Physical review letters [Phys Rev Lett] 2023 Mar 24; Vol. 130 (12), pp. 123603.